John Wiley & Sons Class A

WLY

Market cap $2.13B

John Wiley & Sons (WLY) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

MMS, BFH and WLY made it to the Zacks Rank #1 (Strong Buy) value stocks list on April 17th, 2026.

TPL, LNNGY, KTB, RRBI and WLY have been added to the Zacks Rank #1 (Strong Buy) List on April 17, 2026.

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today announced that its Board of Directors has declared a quarterly cash dividend of $0.355 per share on its Class A and Class B Common Stock, payable on April 23, 2026, to shareholders of record on April 7, 2026. The quarterly dividend is equivalent to an annual dividend of $1.42 per share, an increase from.

John Wiley & Sons, Inc. (WLY) Q3 2026 Earnings Call Transcript

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, today reported results for the third quarter ended January 31, 2026. THIRD QUARTER SUMMARY GAAP performance vs. prior year: Revenue of $410 million up 1%; Operating Income of $63 million up 21%; and Diluted Earnings Per Share (EPS) of $0.56 compared to prior year loss of ($0.43) Adjusted Results at constant c.

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY), a global leader in authoritative content and research intelligence for the advancement of clinical practice, scientific discovery and learning, and OpenEvidence, the most widely used medical AI platform in the world, today announced a strategic partnership to bring Wiley's trusted scientific and medical content into OpenEvidence. Through the partnership, physicians using OpenEvidence at the point of care can rely on content from hundreds of Wil.

HOBOKEN, N.J.--(BUSINESS WIRE)--Wiley (NYSE: WLY and WLYB), a global leader in authoritative content and research intelligence for the advancement of scientific discovery, innovation, and learning, will release its third quarter 2026 results prior to market open on Thursday March 5, 2026. The Company has scheduled a conference call beginning at 10am ET that day to discuss the results. Access webcast at Investor Relations at investors.wiley.com, or directly at http://events.q4inc.com/attendee/46.

Dividends are one of the best benefits to being a shareholder, but finding a great dividend stock is no easy task. Does John Wiley & Sons (WLY) have what it takes?

John Wiley & Sons delivers solid margin improvement and research sales growth, aided by high-margin AI licensing revenues. WLY faces structural headwinds in its learning segment due to weak white-collar job markets and potential long-term enrollment declines from LLM disruption. Despite mixed segment performance, WLY maintains strong FCF generation, robust buybacks, and a combined yield near 13% after recent price declines.